Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Lesperance
Prs10 - Population Health Impact of Omalizumab Over 11 Years of Use in Ireland in Moderate to Severe Allergic Asthma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Effect of Omalizumab on Lung Function and Eosinophil Levels in Adolescents With Moderate-To-Severe Allergic Asthma
Annals of Allergy, Asthma and Immunology
Respiratory Medicine
Pulmonary
Allergy
Immunology
Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Omalizumab Reduced Inhaled Corticosteroid Use and Exacerbations in Childhood Allergic Asthma
Evidence-Based Medicine
Medicine
A Randomized, Open-Label, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Omalizumab in the Treatment of Persistent Moderate and Severe Allergic Asthma and Persistent Allergic Rhinitis in Pediatric Patients 6 to 17 Years of Age
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria
Pediatrics
Child Health
Pediatrics
Perinatology
Selectivity and Specificity Are the Keys to Cost-Effective Use of Omalizumab for Allergic Asthma
Journal of Managed Care Pharmacy
Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
ABS37: Add-On Omalizumab Improves Asthma Control Across Multiple Measures of Response in Patients With Severe Persistent Allergic (IgE-mediated) Asthma
Primary Care Respiratory Journal
